A new study from Flinders University offers insight into how two of the world’s most popular beverages, coffee and tea, may influence bone health in older women.

 

The research, published in the journal Nutrients, followed nearly 10,000 women aged 65 and older over a decade to explore whether their daily habits of sipping coffee or tea were linked to changes in bone mineral density (BMD), a key indicator of osteoporosis risk. The study found that tea drinkers had slightly higher hip bone mineral density

A new study by a team of UK researchers analysed nearly 10,000 deaths between 2016 and 2021, making it the largest global study examining epilepsy-related mortality in adults with intellectual disabilities and epilepsy. It found epilepsy was the primary cause of death in just over 16% of those people, and that they died at a significantly younger average age – 56 compared to 62 – than those who had issues other than epilepsy listed as the primary cause of death in their health records. The study particularly highlights significant disparities in epilepsy-related mortality based on ethnicity, with African and Asian individuals dying younger – at an average age of just 36 – than their White British counterparts.

Societal and behavioral shifts including growing recognition of children displaying harmful sexual behaviors and links to extremism, violence and financial scams are driving child sexual exploitation and abuse online according to a new report.

A landmark UK study has revealed that acute heavy menstrual bleeding (HMB) is placing a significant hidden burden on the NHS, with around £13 million spent annually on hospital admissions and post-discharge care.

For adults who have recovered from depression with the help of antidepressants, gradually reducing medication together with psychological support appears to be as effective as remaining on antidepressants for preventing relapse, according to a systematic review and network meta-analysis of 76 randomised controlled trials, published in The Lancet Psychiatry journal.

NOTES TO EDITORS

The study did not receive any funding. It was conducted by researchers from the University of Verona, Verona, Italy; Université de Rennes, Rennes, France; Universitaire de France, Paris, France; and University of Padova, Padova, Italy.

The labels have been added to this press release as part of a project run by the Academy of Medical Sciences seeking to improve the communication of evidence. For more information, please see: http://www.sciencemediacentre.org/wp-content/uploads/2018/01/AMS-press-release-labelling-system-GUIDANCE.pdf if you have any questions or feedback, please contact The Lancet press office pressoffice@lancet.com

IF YOU WISH TO PROVIDE A LINK FOR YOUR READERS, PLEASE USE THE FOLLOWING, WHICH WILL GO LIVE AT THE TIME THE EMBARGO LIFTS: For Article: https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(25)00330-X/fulltext

For linked Comment: https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(25)00361-X/fulltext

Teenagers who are unhappy with their bodies are more likely to develop symptoms of eating disorders and depression in early adulthood, according to a new study led by University College London (UCL) researchers.

Researchers at UCLA have developed an artificial intelligence tool that can use electronic health records to identify patients with undiagnosed Alzheimer’s disease, addressing a critical gap in Alzheimer’s care: significant underdiagnosis, particularly among underrepresented communities.

Researchers at Duke University used CRISPR technologies to discover previously unannotated stretches of DNA in the ‘dark genome’ that are responsible for controlling how cells sense and respond to the mechanical properties of their local environment.

 

Understanding how these DNA sequences affect cellular identity and function could give researchers new therapeutic targets for illnesses that involve changes to mechanical properties of tissues, including fibrosis, cancer and stroke.

A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can generate deep and durable responses in extramedullary multiple myeloma — one of the most aggressive and treatment-resistant forms of the disease.